Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marc Espié"'
Autor:
David, Groheux, Lucie, Biard, Sylvie, Giacchetti, Luis, Teixeira, Elif, Hindié, Caroline, Cuvier, Laetitia, Vercellino, Pascal, Merlet, Anne, de Roquancourt, Patricia, de Cremoux, Matthieu, Resche-Rigon, Marc, Espié
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 57(4)
Patients with triple-negative breast cancer (TNBC) have poor outcome when pathologic complete response (pCR) is not reached after neoadjuvant chemotherapy. Early prediction would be helpful. We evaluated the association between metabolic response aft
Autor:
Patricia de Cremoux, Mathieu Hatt, Matthieu Resche-Rigon, Pascal Merlet, Mohamed Majdoub, Elif Hindié, Luis Augusto Teixeira, Marc Espié, David Groheux, Alice Sanna, Sylvie Giacchetti, Dimitris Visvikis, Anne de Roquancourt
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 56(6)
This study investigated whether (18)F-FDG PET/CT performed at baseline and during neoadjuvant chemotherapy (NAC) was able to early depict estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer patients
Autor:
Christophe Hennequin, Sylvie Giacchetti, Laetitia Vercellino, Pascal Merlet, David Groheux, Marc Espié, Caroline Cuvier, Marc Delord, Elif Hindié, Marie-Elisabeth Toubert
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 54(1)
The prognosis of patients with locally advanced breast cancer (LABC) remains poor. We prospectively investigated the impact of 18F-FDG PET/CT at initial staging in this clinical setting and compared PET/CT performance with that of conventional distan
Autor:
Isabelle Brenot-Rossi, Marc Espié, Jean-Luc Moretti, Elif Hindié, Domenico Rubello, David Groheux
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 52(3)
Axillary node status is a major prognostic factor in early breast cancer. Staging with sentinel node biopsy (SNB) leads to a substantial reduction in surgical morbidity. Recent multiinstitutional studies revealed SNB false-negative rates ranging from